Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice-Reference-Cited by-同舟云学术

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice

Published:2019-04-19 Issue:14 Volume:25 Page:4264-4270
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Roeker Lindsey E.,Fox Christopher P.^ORCID,Eyre Toby A.,Brander Danielle M.,Allan John N.^ORCID,Schuster Stephen J.,Nabhan Chadi,Hill Brian T.,Shah Nirav N.,Lansigan Frederick^ORCID,Yazdy Maryam^ORCID,Cheson Bruce D.,Lamanna Nicole,Singavi Arun K.,Coombs Catherine C.,Barr Paul M.^ORCID,Skarbnik Alan P.,Shadman Mazyar,Ujjani Chaitra S.,Tuncer Hande H.,Winter Allison M.,Rhodes Joanna^ORCID,Dorsey Colleen,Morse Hannah,Kabel Charlene,Pagel John M.,Williams Annalynn M.,Jacobs Ryan,Goy Andre,Muralikrishnan Sivraj^ORCID,Pearson Laurie,Sitlinger Andrea^ORCID,Bailey Neil,Schuh Anna,Kirkwood Amy A.,Mato Anthony R.

Funder

HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance;International Journal of Hematology;2024-08-21

2. Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities;HemaSphere;2024-07

3. The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review;Cancers;2024-05-30

4. Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study;Annals of Hematology;2024-02-29

5. Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care;Cancers;2024-02-28